Antipsychotics use in dementia: How safe are they?

Antipsychotics use in dementia: How safe are they?

Introduction Antipsychotics are frequently used for managing psychiatric and behavioral symptoms of dementia. However, it’s an off-label resource which remains controversial due to significant safety concerns in the elderly population, namely increasing cardiovascular adverse effects. Objectives...

Full description

Bibliographic Details
Main Author:	C. Lopes
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-04-01
Series:	European Psychiatry
Subjects:	dementia safety Antipsychotics
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933821011342/type/journal_article

Similar Items

Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
by: Valeria Calsolaro, et al.
Published: (2021-03-01)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
by: Manuel Enrique Machado-Duque, et al.
Published: (2021-05-01)

Healthcare professionals' experiences with the use of antipsychotics in dementia
by: Sidsel Maria Jørgensen, et al.
Published: (2024-06-01)

Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia – a review of the Swedish context
by: Staffan Karlsson, et al.
Published: (2017-07-01)

Deprescribing antipsychotics in long term care patients with dementia
by: Patricia Bravo-José, et al.
Published: (2019-07-01)

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)
by: Haider Saddam Qasim, et al.
Published: (2022-06-01)

Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review
by: Haider Qasim, et al.
Published: (2023-06-01)

Assessment of the Risk of Antipsychotics in Patients with Dementia in Actual Clinical Practice in Primary Health Care
by: María del Carmen González-López, et al.
Published: (2021-09-01)

Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors
by: Sebastian Rios, et al.
Published: (2017-10-01)

Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy
by: Bargagli AM, et al.
Published: (2019-11-01)

The (ANTI)psychotic paradox: Lewy body dementia
by: J. Galvañ, et al.
Published: (2021-04-01)

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
by: Stephanie Hsieh, et al.
Published: (2021-11-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
by: Tessa A. Hulshof, et al.
Published: (2020-02-01)

Development of a tool for monitoring the prescribing of antipsychotic medications to people with dementia in general practice: a modified eDelphi consensus study
by: Jennings AA, et al.
Published: (2018-10-01)

Antipsychotics in Alzheimer's disease: A critical analysis
by: Eduardo Marques da Silva, et al.

Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use
by: Chen YJ, et al.
Published: (2024-03-01)

Eficácia e segurança dos antipsicóticos atípicos nas demências: uma revisão sistemática Efficacy and safety of atypical antipsychotics in dementia: a sistematic review
by: Melissa Guarieiro Ramos, et al.
Published: (2006-01-01)

The Prevalence of and Documented Indications for Antipsychotic Prescribing in Irish Nursing Homes
by: Jayne E. Kelleher, et al.
Published: (2021-09-01)

Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use
by: Eva-Maria Gebauer, et al.
Published: (2022-12-01)

Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis
by: Sanja Zivkovic, et al.
Published: (2019-06-01)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
by: D. Ivashchenko, et al.
Published: (2022-06-01)

A nursing mentoring programme on non‐pharmacological interventions against BPSD: Effectiveness and use of antipsychotics—A retrospective, before–after study
by: Roxane Plante‐Lepage, et al.
Published: (2022-01-01)

How to manage antipsychotic-induced akathisia
by: N. Moura, et al.
Published: (2021-04-01)

Use of atypical antipsychotics in the elderly: a clinical review
by: Gareri P, et al.
Published: (2014-08-01)

Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study
by: Kieran A. Walsh, et al.
Published: (2022-12-01)

Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
by: Alok Joshi, et al.
Published: (2022-10-01)

Experiences managing behavioral symptoms among Latino caregivers of Latino older adults with dementia and memory problems: a qualitative study
by: Michelle S. Keller, et al.
Published: (2024-08-01)

Use of antipsychotics with tamoxifen
by: H. Ghabi, et al.
Published: (2021-04-01)

Risk of falls or fall-related injuries associated with potentially inappropriate medication use among older adults with dementia
by: Arum Moon, et al.
Published: (2024-08-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project
by: Juraj Secnik, et al.
Published: (2023-01-01)

Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01)

Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States
by: Joan Forns, et al.
Published: (2022-10-01)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
by: A. González-Rodríguez, et al.
Published: (2021-04-01)

Antipsychotic use in a resource-limited setting: Findings in an Eastern Cape psychiatric hospital
by: Ingrid Eloff, et al.
Published: (2017-07-01)

Some novelties and recommendations by swithing antipsychotics
by: Nika Aleksandra Kravos, et al.
Published: (2014-11-01)

Intellectual disability and antipsychotics
by: I. Cuevas Iñiguez, et al.
Published: (2021-04-01)

Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01)

An investigation of new medications initiation during ambulatory care visits in patients with dementia
by: Alexandra Wallem, et al.
Published: (2021-09-01)